Training School - Drug Discovery and Development

Training School


4 Oct 2017 to 6 Oct 2017


Novartis Campus


Basel, Switzerland

Drug Discovery and Development
4th-6th October 2017
Novartis Campus, Basel, Switzerland


The training school aims to give insights into drug discovery and development. The core of the course is an interactive and group discussion simulation of a drug discovery project from discovering to launching a new medicine (day 2 and 3). Each participant will be assigned a role in the project team and need to come prepared to the course. Participants will encounter and make decisions about various scientific challenges and possible research path. The team will choose a therapeutic indication and drug target, search for potential chemical leads, optimize and progress these leads through preclinical research, demonstrating that selected drug candidate is safe and effective in patients, advance the drug through clinical trials, and ultimately submit the drug for registration with health authorities.  To prepare participants for this interactive course they will get an introduction into preclinical and clinical drug discovery and development and also meet with experts to discuss their assigned roles (day 1). 


Upon completion of the course, participants will be able to: 

  • Explain and discuss unmet medical need, knowledge of mechanism, disease opportunities, and other factors considered when evaluating/pursuing a therapeutic target
  • Describe in general terms the stages of drug discovery and development and what activities typically occur in those stages
  • Explain the contribution of different scientific/clinical disciplines to drug discovery and development
  • Propose and justify key elements of decision-making studies, both pre-clinical and clinical, and recognize the importance of identifying the critical path unique to each project necessary to move it forward
  • Recognize and discuss challenges a project team may encounter in their mission to discover and develop a new drug